KALOFONOS ISABEL (Chief Commercial Officer) received a stock award from CRINETICS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/25/2026ACC: 0001628280-26-011715
Officer· Chief Commercial Officer
Since Feb 2026
+89K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
89K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34K
Price / share
—
Trade value
—
% of position
4076.7%
2/23/2026
834.00→34.83K
Total
Net shares
+34K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | A · Award | +34K | — | — | 4076.7% | 834.00 | 34.83K |
| Total | +34K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
55K shares
Shares
+55K
Strike price
43.79
Held after
55K
Exercisable
—
2/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock55K shares | 2/23/2026 | A · Award | +55K | 43.79 | — | 55K |